Sanuwave Health Receivables 2010-2024 | SNWVD

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sanuwave Health receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sanuwave Health receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$198.7B
Stryker (SYK)	$134.5B
Boston Scientific (BSX)	$124.8B
Medtronic (MDT)	$116.2B
EssilorLuxottica (ESLOY)	$108B
Lonza Group Ag (LZAGY)	$46.2B
Haleon (HLN)	$44.6B
ResMed (RMD)	$37.6B
Koninklijke Philips (PHG)	$29.8B
Terumo (TRUMY)	$28.5B
Zimmer Biomet Holdings (ZBH)	$20.8B
Baxter (BAX)	$18.4B
Insulet (PODD)	$16.4B
Smith & Nephew SNATS (SNN)	$12.4B
Bio-Rad Laboratories (BIO)	$8.9B
Demant (WILYY)	$8.5B
BellRing Brands (BRBR)	$8.3B
Lantheus Holdings (LNTH)	$7.7B
ICU Medical (ICUI)	$4.3B
Haemonetics (HAE)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.6B
TG Therapeutics (TGTX)	$3.6B
Perrigo (PRGO)	$3.4B
Envista Holdings (NVST)	$3.2B
Neogen (NEOG)	$3B
GN Store Nord (GNNDY)	$2.9B
QuidelOrtho (QDEL)	$2.6B
Agios Pharmaceuticals (AGIO)	$2.6B
Green Thumb Industries (GTBIF)	$2.3B
Curaleaf Holdings (CURLF)	$2.2B